Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells

• Angeliki Korpetinou,

  Affiliation Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

  ⨯
• Spyros S. Skandalis,

  Affiliation Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

  ⨯
• Aristidis Moustakas,

  Affiliation Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, Uppsala, Sweden

  ⨯
• Kaisa E. Happonen,

  Affiliation Department of Laboratory Medicine, Division of Medical Protein Chemistry, Lund University, Malmö, Sweden

  ⨯
• Heidi Tveit,

  Affiliation Department of Molecular Biosciences, University of Oslo, Oslo, Norway

  ⨯
• Kristian Prydz,

  Affiliation Department of Molecular Biosciences, University of Oslo, Oslo, Norway

  ⨯
• Vassiliki T. Labropoulou,

  Affiliation Karamandaneion Childrens’ Hospital, Patras, Greece

  ⨯
• Efstathia Giannopoulou,

  Affiliation Clinical Oncology Laboratory, Division of Oncology, University Hospital of Patras, Patras Medical School, Patras, Greece

  ⨯
• Haralambos P. Kalofonos,

  Affiliation Clinical Oncology Laboratory, Division of Oncology, University Hospital of Patras, Patras Medical School, Patras, Greece

  ⨯
• Anna M. Blom,

  Affiliation Department of Laboratory Medicine, Division of Medical Protein Chemistry, Lund University, Malmö, Sweden

  ⨯
• Nikos K. Karamanos,

  Affiliation Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

  ⨯
• Achilleas D. Theocharis

  * E-mail: atheoch@upatras.gr

  Affiliation Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patras, Greece

  ⨯